Multiple Myeloma Biological: bb2121 Drug: Daratumumab Drug: Pomalidomide Drug: Dexamethasone Drug: Bortezomib Drug: Ixazomib Drug: Lenalidomide Phase 3Estimated Primary Completion Date : June 23, 2025Estimated Study Completion Date : June 23, 2025Moffit Cancer Center RecruitingSarah Cannon Research Institute Center for Blood Recruiting
